3rd Quarter - Report

CROSSROADS STRATEGIES, LLC for EISAI, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to tax reform; international taxation.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Issues related to supply chain and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 891 (119th), H.R. 8800 (119th), S. 4784 (119th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models); drug pricing; H.R.6130, Alzheimers Screening and Prevention (ASAP) Act of 2025.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6130 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.